KCM
Kingdon Capital Management Portfolio holdings
AUM
$518M
This Quarter Return
+9.17%
1 Year Return
+18.14%
3 Year Return
+127%
5 Year Return
+215.17%
10 Year Return
+696.09%
AUM
$525M
AUM Growth
+$525M
(-4%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-31.54%
Top 10 Holdings %
Top 10 Hldgs %
39.31%
Holding
93
New
13
Increased
14
Reduced
21
Closed
15
Top Buys
| 1 |
Teck Resources
TECK
|
$21.1M |
| 2 |
Dell
DELL
|
$16.4M |
| 3 |
Sherwin-Williams
SHW
|
$16.3M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$16.1M |
| 5 |
Insmed
INSM
|
$12.6M |
Top Sells
| 1 |
Danaher
DHR
|
$26.8M |
| 2 |
Meta Platforms (Facebook)
META
|
$18.6M |
| 3 |
Mattel
MAT
|
$14.3M |
| 4 |
Corteva
CTVA
|
$12.5M |
| 5 |
Acadia Healthcare
ACHC
|
$12.1M |
Sector Composition
| 1 | Industrials | 26.98% |
| 2 | Healthcare | 25.54% |
| 3 | Technology | 15.62% |
| 4 | Materials | 7.3% |
| 5 | Financials | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Visa
V
$681B
| $7.81M | 0.98% |
30,000
-35,000
| -54% | -$9.11M |
|
27
Praxis Precision Medicines
PRAX
$980M
| $7.72M | 0.97% |
346,665
-2
| -0% | -$45 |
|
28
Alight
ALIT
$2.07B
| $7.68M | 0.96% |
+900,000
| New | +$7.68M |
|
29
Mastercard
MA
$536B
| $7.46M | 0.93% |
+17,500
| New | +$7.46M |
|
30
NexGen Energy
NXE
$4.5B
| $7M | 0.88% |
+1,000,000
| New | +$7M |
|
31
Quanta Services
PWR
$55.8B
| $6.95M | 0.87% |
32,200
-7,366
| -19% | -$1.59M |
|
32
Celestica
CLS
$24.4B
| $6.59M | 0.82% |
225,000
+25,000
| +13% | +$732K |
|
33
Curtiss-Wright
CW
$18B
| $6.52M | 0.82% |
29,278
-150
| -0.5% | -$33.4K |
|
34
LivaNova
LIVN
$3.09B
| $6.26M | 0.78% |
121,000
-13,700
| -10% | -$709K |
|
35
RenaissanceRe
RNR
$11.6B
| $5.88M | 0.74% |
30,000
-60,000
| -67% | -$11.8M |
|
36
Tandem Diabetes Care
TNDM
$834M
| $5.74M | 0.72% |
+194,200
| New | +$5.74M |
|
37
BWX Technologies
BWXT
$14.7B
| $5.51M | 0.69% |
71,857
-99,000
| -58% | -$7.6M |
|
38
MGP Ingredients
MGPI
$622M
| $5.42M | 0.68% |
55,000
+14,200
| +35% | +$1.4M |
|
39
KBR
KBR
$6.44B
| $5.26M | 0.66% |
95,000
-140,000
| -60% | -$7.76M |
|
|
OPTN
40
DELISTED
OptiNose
OPTN
| $5.03M | 0.63% |
259,949
+13,333
| +5% | +$258K |
|
41
SCYNEXIS
SCYX
$35.2M
| $4.99M | 0.62% |
2,237,048
+359,900
| +19% | +$803K |
|
42
Tenet Healthcare
THC
$16.5B
| $4.83M | 0.6% |
+63,950
| New | +$4.83M |
|
43
Olema Pharmaceuticals
OLMA
$432M
| $4.21M | 0.53% |
300,000
+90,000
| +43% | +$1.26M |
|
44
Curis
CRIS
$21.5M
| $3.62M | 0.45% |
284,150
-25,000
| -8% | -$319K |
|
45
WNS Holdings
WNS
$3.24B
| $3.48M | 0.44% |
55,000
-25,000
| -31% | -$1.58M |
|
46
enVVeno Medical
NVNO
$15M
| $3.18M | 0.4% |
619,180
+400,000
| +182% | +$2.06M |
|
47
X4 Pharmaceuticals
XFOR
$70M
| $2.91M | 0.36% |
115,789
+50,000
| +76% | +$1.26M |
|
48
Jasper Therapeutics
JSPR
$44.2M
| $2.79M | 0.35% |
354,000
+50,000
| +16% | +$395K |
|
49
Great Elm Group
GEG
$89.6M
| $2.69M | 0.34% |
1,388,907
+9,858
| +0.7% | +$19.1K |
|
50
Beyond Air
XAIR
$12.1M
| $2.67M | 0.33% |
68,178
| – | – |
|